Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Vogt

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Atherosclerosis|June 16, 2018
Reply to: "Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis: Corrections of the report on the randomized MICA-study"Elisa Waldmann, Anja Vogt, Alexander Crispin, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 28, 2004
Autosomal recessive hypercholesterolemia in three sisters with phenotypic homozygous familial hypercholesterolemia: diagnostic and therapeutic proceduresHans-P Thomas, Anja Vogt, Kenneth R Wilund, et al.
The American Journal of Cardiology|February 24, 2007
Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study)Christie M Ballantyne, Robert Weiss, Tiziano Moccetti, et al.
Ecotoxicology and Environmental Safety|January 10, 2015
Organophosphorus insecticides in honey, pollen and bees (Apis mellifera L.) and their potential hazard to bee colonies in EgyptYahya Al Naggar, Garry Codling, Anja Vogt, et al.
Nanoimpact|April 4, 2026
Effects of micro/nanoplastics combined with three anthropogenic chemicals on larval zebrafish (Danio rerio): study of toxicity, behaviour and assessment of uptakeLudovic Hermabessiere, Bailey Levesque, Violet Chilvers, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 8, 2007
Endothelial cell dysfunction after coronary artery bypass grafting with extracorporeal circulation in patients with type 2 diabetes mellitusKarla Lehle, Jürgen G Preuner, Anja Vogt, et al.
Atherosclerosis|January 25, 2023
Long-term persistence with evolocumab treatment and sustained reductions in LDL-cholesterol levels over 30 months: Final results from the European observational HEYMANS studyKausik K Ray, Eric Bruckert, Pasquale Peronne-Filardi, et al.
Atherosclerosis. Supplements|December 11, 2019
Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresisReinhard Klingel, Franz Heigl, Volker Schettler, et al.
Cardiovascular Diabetology|October 17, 2008
Dyslipidemia in primary care--prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)Elisabeth Steinhagen-Thiessen, Peter Bramlage, Christian Lösch, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 17, 2022
Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS studyKausik K Ray, Nafeesa Dhalwani, Mahendra Sibartie, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Atherosclerosis|June 16, 2018
Reply to: "Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis: Corrections of the report on the randomized MICA-study"Elisa Waldmann, Anja Vogt, Alexander Crispin, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 28, 2004
Autosomal recessive hypercholesterolemia in three sisters with phenotypic homozygous familial hypercholesterolemia: diagnostic and therapeutic proceduresHans-P Thomas, Anja Vogt, Kenneth R Wilund, et al.
The American Journal of Cardiology|February 24, 2007
Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study)Christie M Ballantyne, Robert Weiss, Tiziano Moccetti, et al.
Ecotoxicology and Environmental Safety|January 10, 2015
Organophosphorus insecticides in honey, pollen and bees (Apis mellifera L.) and their potential hazard to bee colonies in EgyptYahya Al Naggar, Garry Codling, Anja Vogt, et al.
Nanoimpact|April 4, 2026
Effects of micro/nanoplastics combined with three anthropogenic chemicals on larval zebrafish (Danio rerio): study of toxicity, behaviour and assessment of uptakeLudovic Hermabessiere, Bailey Levesque, Violet Chilvers, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 8, 2007
Endothelial cell dysfunction after coronary artery bypass grafting with extracorporeal circulation in patients with type 2 diabetes mellitusKarla Lehle, Jürgen G Preuner, Anja Vogt, et al.
Atherosclerosis|January 25, 2023
Long-term persistence with evolocumab treatment and sustained reductions in LDL-cholesterol levels over 30 months: Final results from the European observational HEYMANS studyKausik K Ray, Eric Bruckert, Pasquale Peronne-Filardi, et al.
Atherosclerosis. Supplements|December 11, 2019
Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresisReinhard Klingel, Franz Heigl, Volker Schettler, et al.
Cardiovascular Diabetology|October 17, 2008
Dyslipidemia in primary care--prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)Elisabeth Steinhagen-Thiessen, Peter Bramlage, Christian Lösch, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 17, 2022
Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS studyKausik K Ray, Nafeesa Dhalwani, Mahendra Sibartie, et al.
Pageof 6